[an error occurred while processing this directive]
C&EN logo The Newsmagazine of the Chemical World
Home Current Issue ChemJobs Join ACS
Latest News
Government & Policy
Careers and Employment
ACS News
How to log in
Contact Us
Site Map
About C&EN
About the Magazine
How to Subscribe
How to Advertise

Latest News RSS Feed

latest news RSS feedWhat is this?

Join ACS
Join ACS
  Latest News  
  September 27,  2004
Volume 82, Number 39
p. 7


First total synthesis of complex antibiotic with unusual mechanism

  Thiostrepton, an extraordinarily complex bacterial natural product that's used as a topical veterinary antibiotic and also has promising antimalarial and anticancer activity, has yielded to total chemical synthesis.

First isolated from bacteria in 1955, thiostrepton has an unusual type of antibiotic activity: It disables protein biosynthesis by binding to ribosomal RNA and one of its associated proteins. British crystallographer and 1964 Nobel Prize winner Dorothy Crowfoot Hodgkin solved the structure in 1970.

Thiostrepton includes 10 rings, 11 peptide bonds, extensive unsaturation, and 17 stereogenic centers. More challenging still, it is highly acid- and base-sensitive. It's the parent compound and the most complex member of a family of thiopeptide antibiotics.

Now, the compound has succumbed to the synthetic blandishments of chemistry professor K. C. Nicolaou and coworkers at Scripps Research Institute and the University of California, San Diego [Angew. Chem. Int. Ed., 43, 5087 and 5092 (2004)].

"It's a landmark synthesis and an outstanding achievement by the Nicolaou group," comments senior research fellow Christopher J. Moody of the department of chemistry at the University of Exeter, in England. Moody's group had earlier synthesized two smaller thiopeptide antibiotics, promothicin and amythiamicin D.

The linchpin of thiostrepton's structure is a dehydropiperidine ring that supports a bisdehydroalanine tail and two macrocycles--a 26-membered thiazoline-containing ring and a 27-membered quinaldic acid system. Nicolaou and coworkers created the critical dehydropiperidine ring from simple starting materials through a biomimetic hetero-Diels-Alder dimerization. This key step helps validate a 1978 proposal that bacteria use this kind of reaction to biosynthesize thiopeptide antibiotics.

Nicolaou and coworkers incorporated the dehydropiperidine into the thiazoline-containing macrocycle. They combined that macrocycle with a quinaldic acid-containing structure and a bisdehydroalanine-tail precursor unit. They then elaborated the product to obtain thiostrepton.

A reviewer of the group's two papers says the synthesis "is a masterpiece that highlights state-of-the-art technique and opens the field to meaningful structure-activity and mode-of-action studies."

  Chemical & Engineering News
ISSN 0009-2347
Copyright © 2004

E-mail this article
to a friend
Print this article
E-mail the editor